← Leaderboards
M. Sue Sue O'Dorisio
University Of Iowa
$9,044,145
Attributed
$10,649,526
Total exposure
19
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$21,269,707 · 18
FDA$429,386 · 2
By mechanism
P50$12,517,304 · 3
R01$5,073,333 · 5
R21$1,813,059 · 3
T32$1,490,237 · 1
KL2$674,792 · 1
U56$73,750 · 1
Top collaborators
- Yusuf Menda5 shared
- David L Bushnell2 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Dawn E Quelle$8,297,216
- Yusuf Menda$5,445,305
- David L Bushnell$1,807,167
- Charles S Davis$0
- Thomas Odorisio$1,421,462
Others in their field
Top investigators on “Neuroendocrine Tumors”
- David Macpherson · Carnegie Institution Of Washington, D.C.$11,499,752
- Julien Sage · University Of California Santa Cruz$10,217,874
- David J. Kwiatkowski · Brigham And Women'S Hospital$8,874,846
- James A Decaprio · Dana-Farber Cancer Institute$7,914,342
- Himisha Beltran · Dana-Farber Cancer Inst$7,515,798
- Michael King Schultz · Viewpoint Molecular Targeting, Inc.$6,896,677
Research focus
Neuroendocrine TumorsChildClinical ResearchIowaUniversitiesTranslatingAdultMalignant NeoplasmsEarly DiagnosisInnovationTumorDiagnosticToxic EffectImageKidneyTranslational ResearchCommunicationDesignCareer DevelopmentNovel TherapeuticsGrantMeetingsSpecialized Program Of Research ExcellenceNovel Diagnostics
Grant awards (55)
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer$500,000
P50 · FY2021 · CA · contact PI
Core A: Administration$54,936
P50 · FY2021 · CA · contact PI
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer$1,478,968
P50 · FY2020 · CA · contact PI
Core A: Administration$112,368
P50 · FY2020 · CA · contact PI
Core A: Administration$234,868
P50 · FY2019 · CA · contact PI
Admin-Core-001$123,600
P50 · FY2019 · CA · contact PI
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer$123,600
P50 · FY2019 · CA · contact PI
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer$2,300,000
P50 · FY2018 · CA · contact PI
The University of Iowa Clinical and Translational Science Award$674,792
KL2 · FY2018 · TR · contact PI
Core A: Administration$245,085
P50 · FY2018 · CA · contact PI
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer$2,300,000
P50 · FY2017 · CA · contact PI
Core A: Administration$242,194
P50 · FY2017 · CA · contact PI
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer$2,161,999
P50 · FY2016 · CA · contact PI
Image-guided Diagnosis and Therapy of Neuroendocrine Tumors$511,972
R01 · FY2016 · CA · contact PI
Core A: Administration$227,375
P50 · FY2016 · CA · contact PI
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer$2,185,000
P50 · FY2015 · CA · contact PI
Image-guided Diagnosis and Therapy of Neuroendocrine Tumors$519,131
R01 · FY2015 · CA · contact PI
Core A: Administration$227,311
P50 · FY2015 · CA · contact PI
Image-guided Diagnosis and Therapy of Neuroendocrine Tumors$509,922
R01 · FY2014 · CA · contact PI
National Research Service Award Institutional Research Training Grants (T32)$143,493
T32 · FY2014 · HL · contact PI
Image-guided Diagnosis and Therapy of Neuroendocrine Tumors$509,568
R01 · FY2013 · CA · contact PI
National Research Service Award Institutional Research Training Grants (T32)$203,850
T32 · FY2013 · HL · contact PI
Image-guided Diagnosis and Therapy of Neuroendocrine Tumors$544,907
R01 · FY2012 · CA · contact PI
National Research Service Award Institutional Research Training Grants (T32)$209,174
T32 · FY2012 · HL · contact PI
National Research Service Award Institutional Research Training Grants (T32)$146,128
T32 · FY2011 · HL · contact PI
Dosimetry Guided Phase II of 90Y-DOTA-tyr3-Octreotide + Retinoic Acid in Kids$265,346
R21 · FY2010 · CA · contact PI
National Research Service Award Institutional Research Training Grants (T32)$203,134
T32 · FY2010 · HL · contact PI
DOSIMETRY IN CHILDREN AND YOUNG ADULTS WITH NEUROBLASTOMA OR NEUROENDOCRINE TUMOR$306,762
R21 · FY2009 · CA · contact PI
Dosimetry Guided Phase II of 90Y-DOTA-tyr3-Octreotide + Retinoic Acid in Kids$270,950
R21 · FY2009 · CA · contact PI
Hemotologic and Oncologic Diseases of Childhood$105,731
T32 · FY2009 · HL · contact PI
DOSIMETRY IN CHILDREN AND YOUNG ADULTS WITH NEUROBLASTOMA OR NEUROENDOCRINE TUMOR$308,501
R21 · FY2008 · CA · contact PI
Hemotologic and Oncologic Diseases of Childhood$122,980
T32 · FY2008 · HL · contact PI
PHASE I TRIAL OF 90Y-DOTA-TYR3-OCTREOTIDE IN CHILDREN W*$59,000
R01 · FY2008 · FD · contact PI
PHASE I TRIAL OF 90Y-DOTA-TYR3-OCTREOTIDE IN CHILDREN W*$185,193
R01 · FY2007 · FD · contact PI
Hemotologic and Oncologic Diseases of Childhood$172,369
T32 · FY2007 · HL · contact PI
90Y-DOTA-TYR3-OCTREOTIDE ADMINISTERED TO CHILDREN WITH REFRACTORY TUMORS$3,934
M01 · FY2007 · RR · contact PI
CPTK787/ZK222584 IN PATIENTS WITH METASTATIC NEUROENDOCRINE TUMORS$270
M01 · FY2007 · RR · contact PI
PHASE I TRIAL OF 90Y-DOTA-TYR3-OCTREOTIDE IN CHILDREN W*$185,193
R01 · FY2006 · FD · contact PI
Hemotologic and Oncologic Diseases of Childhood$122,980
T32 · FY2006 · HL · contact PI
CPTK787/ZK222584 IN PATIENTS WITH METASTATIC NEUROENDOCRINE TUMORS$7,610
M01 · FY2006 · RR · contact PI
90Y-DOTA-TYR3-OCTREOTIDE ADMINISTERED TO CHILDREN WITH REFRACTORY TUMORS$1,985
M01 · FY2006 · RR · contact PI
Hemotologic and Oncologic Diseases of Childhood$60,398
T32 · FY2005 · HL
90Y-DOTA-TYR3-OCTREOTIDE ADMINISTERED TO CHILDREN WITH REFRACTORY TUMORS$24,604
M01 · FY2005 · RR
90Y-DOTA-TYR3-OCTREOTIDE IN CHILDREN W/SOMATOSTATIN REC*$0
R01 · FY2005 · FD
PHASE I TRIAL OF 90Y-DOTA-TYR3-OCTREOTIDE IN CHILDREN W*$0
R01 · FY2005 · FD
Academic Public Private Partnership Program$73,750
U56 · FY2004 · CA
90Y-DOTA-tyr3-Octreotide Administered to Children$18,215
M01 · FY2004 · RR
RADIORECEPTOR GUIDED SURGERY OF NEURAL CREST TUMORS$540,467
R01 · FY2003 · EB
RADIORECEPTOR GUIDED SURGERY OF NEURAL CREST TUMORS$534,689
R01 · FY2002 · CA
Phase I Trial of 90Y Octreotide in Childhood Solid Tumor$330,750
R21 · FY2002 · CA
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM$0
P30 · FY2002 · CA
RADIORECEPTOR GUIDED SURGERY OF NEURAL CREST TUMORS$530,232
R01 · FY2001 · CA
Phase I Trial of 90Y Octreotide in Childhood Solid Tumor$330,750
R21 · FY2001 · CA
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM$0
P30 · FY2001 · CA
RADIORECEPTOR GUIDED SURGERY OF NEURAL CREST TUMORS$443,059
R01 · FY2000 · CA